15 Sep 2016 13:18
For immediate release: 15 September 2016
TyraTech, Inc.
("TyraTech" or the "Company")
Directors' Dealings
TyraTech, Inc. (AIM: TYR and TYRU), a life sciences technology company focused on nature-derived insect and parasite control products, announces that Jim Hills, Non-Executive Director, purchased 500,000 ordinary shares in the Company on 14th September 2016 at a price of 2.5 pence per ordinary share.
Following this transaction, Mr. Hills is interested in 3,029,957 ordinary shares in the Company representing 0.83 per cent of TyraTech issued share capital (voting rights).
*-ends*-
For further information please visit: www.tyratech.com or contact:
TyraTech Inc. Bruno Jactel, Chief Executive Officer Erica Boisvert, Chief Financial Officer |
Tel: +1 919 415 4340 Tel: +1 919 415 4287 |
SPARK Advisory Partners Limited (Nominated Adviser) Matt Davis / Mark Brady |
Tel: +44 20 3368 3551 |
Allenby Capital Limited (Joint Broker) Chris Crawford |
Tel: +44 20 3328 5656 |
Whitman Howard Limited (Joint Broker) Ranald McGregor-Smith |
Tel: +44 20 7659 1234 |
Belvedere Communications (PR) John West / Kim van Beeck |
Tel: +44 20 3567 0510 |